These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 3915263

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Insulin-receptor interaction in Cushing's syndrome].
    Pallardo Sánchez LF, Grande Aragón C, López López J, Guerrero Martínez E, Albero Gamboa R, Cerdán Vallejo A.
    Rev Clin Esp; 1986 Jun; 179(1):18-21. PubMed ID: 3526431
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Decreased insulin binding and antilipolytic response in adipocytes from patients with Cushing's syndrome.
    Calle C, Carranza MC, Simón MA, Torres A, Mayor P.
    Biosci Rep; 1987 Sep; 7(9):713-9. PubMed ID: 3322423
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Regulation of glucocorticoid receptors in human mononuclear cells: effects of glucocorticoid treatment, Cushing's disease and ketoconazole.
    Pardes E, De Yampey JE, Moses DF, De Nicola AF.
    J Steroid Biochem Mol Biol; 1991 Aug; 39(2):233-8. PubMed ID: 1888683
    [Abstract] [Full Text] [Related]

  • 12. [Insulin resistance in pituitary, thyroid, and adrenal diseases].
    Iitaka M, Katayama S.
    Nihon Rinsho; 2000 Feb; 58(2):451-5. PubMed ID: 10707575
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Glucocorticoid receptors in anorexia nervosa and Cushing's disease.
    Invitti C, Redaelli G, Baldi G, Cavagnini F.
    Biol Psychiatry; 1999 Jun 01; 45(11):1467-71. PubMed ID: 10356629
    [Abstract] [Full Text] [Related]

  • 16. Insulin secretion, insulin sensitivity and glucose-mediated glucose disposal in Cushing's disease: a minimal model analysis.
    Page R, Boolell M, Kalfas A, Sawyer S, Pestell R, Ward G, Alford F.
    Clin Endocrinol (Oxf); 1991 Dec 01; 35(6):509-17. PubMed ID: 1769133
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Decreased ligand affinity rather than glucocorticoid receptor down-regulation in patients with endogenous Cushing's syndrome.
    Huizenga NA, De Herder WW, Koper JW, de Lange P, v D Lely AJ, Brinkmann AO, de Jong FH, Lamberts SW.
    Eur J Endocrinol; 2000 May 01; 142(5):472-6. PubMed ID: 10802524
    [Abstract] [Full Text] [Related]

  • 19. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC, Nieman LK, Oldfield EH, Loughlin T, Barnes KM, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1989 May 01; 68(5):912-6. PubMed ID: 2541160
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.